Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

Journal of Clinical Investigation

Volumn 105, Issue 12, 2000, Pages 1731-1740

  Shaw, Peter X ^a   Hörkkö, Sohvi ^a   Chang, Mi Kyung ^a   Curtiss, Linda K ^b   Palinski, Wulf ^a   Silverman, Gregg J ^a   Witztum, Joseph L ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; DISEASE ASSOCIATION; IMMUNE RESPONSE; MOUSE; NATURAL SELECTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0342939538     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8472     Document Type: Article

References (32)

1. Steinberg, D., and Witztum, J.L. 1999. Lipoproteins, lipoprotein oxidation, and atherogenesis. In Molecular basis of cardiovascular disease. K.R. Chien, editor. W.B Saunders Co. Philadelphia, Pennsylvania, USA. 458-475.
2. Palinski, W., et al. 1994. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler. Thromb. 14:605-616.
3. Palinski, W., et al. 1996. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98:800-814.
4. Palinski, W., Miller, E., and Witztum, J.L. 1995. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. USA. 92:821-825.
5. Freigang, S., Hörkkö, S., Miller, E., Witztum, J.L., and Palinski, W. 1998. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative-neoepitopes. Arterioscler. Thromb. Vasc. Biol. 18:1972-1982.
6. Hörkkö, S., et al. 1999. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 103:117-128.
7. Chang, M., et al. 1999. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. USA. 96:6353-6358.
8. Silverman, G.J., et al. 1998. The dual phases of the response to neonatal exposure to a VH family-restricted staphylococcal B cell superantigen. J. Immunol. 161:5720-5732.
9. Palinski, W., Tangirala, R.K., Miller, E., Young, S.G., and Witztum, J.L. 1995. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15:1569-1576.
10. Gearhart, P.J., Johnson, N.D., Douglas, R., and Hood, L. 1981. IgG antibodies to phosphorylcholine exhibit more diversity than their IgM counterparts. Nature. 291:29-34.
11. Kenny, J.J., et al. 1992. Antigen binding and idiotype analysis of antibodies obtained after electroporation of heavy and light chain genes encoding phosphocholine-specific antibodies: a model for T15-idiotype dominance. J. Exp. Med. 176:1637-1643.
12. Desaymard, C., Giusti, A.M., and Scharff, M.D. 1984. Rat anti-T15 monoclonal antibodies with specificity for VH- and VH-VL epitopes. Mol. Immunol. 21:961-967.
13. Kearney, J.F., Barletta, R., Quan, Z.S., and Quintans, J. 1981. Monoclonal vs. heterogeneous anti-H-8 antibodies in the analysis of the antiphosphorylcholine response in BALB/c mice. Eur. J. Immunol 11:877-883.
14. Taki, S., Schmitt, M., Tarlinton, D., Feorster, I., and Rajewsky, K. 1992. T cell-dependent antibody production by Ly-1 B cells. Ann. N Y Acad. Sci. 651:328-335.
15. Harnett, W., and Harnett, M.M. 1999. Phosphorylcholine: friend or foe of the immune system? Immunol. Today. 20:125-129.
16. Ylä-Herttuala, S., et al. 1994. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14:32-40.
17. Kantor, A.B., Merrill, C.E., Herzenberg, L.A., and Hillson, J.L. 1997. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. Immunol. 158:1175-1186.
18. Briles, D.E., Forman, C., Hudak, S., and Claflin, J.L. 1982. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J. Exp. Med. 156:1177-1185.
19. Shan, H., Shlomchik, M., and Weigert, M. 1990. Heavy-chain class switch does not terminate somatic mutation. J. Exp. Med. 172:531-536.
20. Itabe, H., et al. 1996. Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein. J. Biol. Chem. 271:33208-33217.
21. Claflin, J.L., and Cubberley, M. 1980. Clonal nature of the immune response to phosphocholine. VII. Evidence throughout inbred mice for molecular similarities among antibodies bearing the T15 idiotype. J. Immunol. 125:551-558.
22. Sigal, N.H., Gearhart, P.J., and Klinman, N.R. 1975. The frequency of phosphorylcholine-specific B cells in conventional and germfree BALB/C mice. J. Immunol. 114:1354-1358.
23. Masmoudi, H., Mota-Santos, T., Huetz, F., Coutinho, A., and Cazenave, P.A. 1990. All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. Int. Immunol. 2:515-520.
24. Kantor, A.B., and Herzenberg, L.A. 1993. Origin of murine B cell lineages. Annu. Rev. Immunol. 11:501-538.
25. Pillai, S. 1999. The chosen few? Positive selection and the generation of naive B lymphocytes. Immunity. 10:493-502.
26. Hayakawa, K., et al. 1999. Positive selection of natural autoreactive B cells. Science. 285:113-116.
27. + B cell precursor in B-1 cell differentiation. J. Exp. Med. 187:1325-1334.
28. Lam, K.-P., and Rajewsky, K. 1999. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J. Exp. Med. 190:471-477.
29. Segal, D.M., et al. 1974. The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc. Natl. Acad. Sci. USA. 71:4298-4302.
30. Hörkkö, S., et al. 1996. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J. Clin. Invest. 98:815-825.
31. Hörkkö, S., Miller, E., Branch, D.W., Palinski, W., and Witztum, J.L. 1997. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins). Proc. Natl. Acad. Sci. USA. 94:10356-10361.
32. Napoli, C., et al. 1997. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Invest 100:2680-2690.